Delivery Order SPE2DB22D1017-SPE2DB25FG8TF
Award Date 8/1/25
Potential Completion Date 8/4/25
Potential Value $3.4K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $3,513.76 to AmerisourceBergen Drug Corp for FORTEO 560 MCG/2.24 ML pen injections on August 4, 2025, with completion scheduled for August 5, 2025. This firm fixed-price contract, which carries no set-aside designation, represents a competitive award under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The product will be delivered to AmerisourceBergen's corporate offices in...
- This is a $14,507.25 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of FORTEO 560 MCG/2.24 ML PEN INJ 2.24ML, a medication used to treat osteoporosis. The contract has an ultimate completion date of May 29, 2025 and is not a set-aside contract. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite...
- This is a $17,182.42 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide the medication FORTEO 560 MCG/2.24 ML PEN INJ 2.24ML. The delivery order has an ultimate completion date of June 23, 2025. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to supply a wide range of pharmaceutical and medical products to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for FORTEO (560 mcg/2.24 mL pen injection) with a ceiling value of $8,274.44. The contract is a firm fixed price delivery order with an ultimate completion date of August 5, 2025, and represents a non-competitive set-aside award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location and serve as the prime contractor for this...
- This is a $7,319.57 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of FORTEO 560 MCG/2.24 ML PEN INJ 2.24ML, a pharmaceutical product, with a period of performance through July 2025. The contract is not set aside and was competitively awarded. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,749.98 firm fixed-price contract is for the supply of FORTEO 600 MCG/2.4 ML PEN INJ 2.4ML, a medication used in the treatment of osteoporosis. The contract has an ultimate completion date of March 6, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., to provide 4,563,982,059 units of the pharmaceutical product FORTEO 600 MCG/2.4 ML PEN INJ 2.4ML. The $11,868.34 contract has a period of performance through March 18, 2024 and is not set aside for any special designations. AmerisourceBergen Drug Corp, as the prime contractor, will deliver these pharmaceutical supplies from its corporate office...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,893.04, is for the supply of FORTEO 600 MCG/2.4 ML PEN INJ 2.4ML, a medication used in the treatment of osteoporosis. The contract has a firm fixed price pricing type and an ultimate completion date of February 26, 2025. This delivery order is part of a larger Indefinite Delivery...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,601.43 firm-fixed-price contract is for the delivery of FORTEO 560 MCG/2.24 ML PEN INJ 2.24ML, a medication used in the treatment of osteoporosis. The contract has an ultimate completion date of June 24, 2025 and is not set aside for a specific business category. AmerisourceBergen Drug Corp holds a significant...
- This is a $7,705.44 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of FORTEO 600 MCG/2.4 ML PEN INJ 2.4ML, a specialty medication used in the treatment of osteoporosis. The award has an ultimate completion date of February 28, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...